Laxocodyl

Quick links to important sections

Laxocodyl

Method of action: Laxative

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Laxocodyl

Quick Facts

Property Description
Active Ingredient Bisacodyl
Forms Enteric-coated tablet, Suppository, Oral suspension
Pharmacological Class Stimulant Laxative, Bowel Evacuant
General Purpose To facilitate the evacuation of the colon
Origin Synthetic (Diphenylmethane derivative)

What Type of Medicine is Laxocodyl (Bisacodyl)?

Laxocodyl is a synthetic pharmaceutical agent containing the active ingredient Bisacodyl, which is structurally classified as a diphenylmethane derivative. It is primarily defined as a stimulant laxative, placing it within the broader functional class of gastrointestinal agents. This classification indicates the medicine’s role is to actively prompt the digestive system rather than merely modifying the stool’s consistency.

As a single-agent product, Laxocodyl relies on the specific chemical properties of the Bisacodyl molecule to exert a localized effect on intestinal motility. The active ingredient is designed to produce predictable defecation within a controlled timeframe, serving as a bowel evacuant that achieves its therapeutic goal through direct action.


Understanding the General Purpose of This Bowel Evacuant

The general purpose of Laxocodyl is to facilitate the reliable and efficient evacuation of the colon, offering relief from discomfort associated with difficult or infrequent passage of stool. This therapeutic goal is recognized for its use in patients experiencing acute, temporary constipation. This effect is achieved through the drug's dual physiological action: the promotion of intestinal muscle movement and the enhancement of fluid secretion into the colon.

Bisacodyl acts as a contact laxative by stimulating the nerve endings in the lining of the large intestine, initiating strong peristalsis stimulation. This acceleration of movement, combined with increased water and electrolyte secretion into the lumen, ensures that the stool is propelled and lubricated for the process of defecation induction.


Available Forms of Laxocodyl Preparations

Laxocodyl is supplied in distinct dosage forms to accommodate different administration needs, primarily including the enteric-coated tablet for the oral route and the suppository for rectal use. The tablets are manufactured with a protective coating to ensure the active ingredient is released only in the lower intestine, preventing premature activation and optimizing drug delivery. Both forms utilize essential pharmaceutical excipients to stabilize the Bisacodyl and ensure the correct delivery mechanism.

Regulatory References

  1. Bisacodyl - StatPearls - NCBI Bookshelf (NIH)

What side effects are possible with Laxocodyl?

Possible Side Effects and Safety Information

The safety profile of Laxocodyl (Bisacodyl) is formalized based on classifications and documentation from government regulatory authorities, detailing potential adverse reactions and official safety constraints.

Adverse reactions are primarily linked to the gastrointestinal system and are classified by frequency:

  • Common (may affect up to 1 in 10 people): Includes gastrointestinal discomfort such as abdominal pain, cramping, and diarrhea.
  • Uncommon (may affect up to 1 in 100 people): Documented effects include vomiting, dizziness, and the presence of blood in the stool (hematochezia).
  • Rare (may affect up to 1 in 1,000 people): Includes syncope (fainting), which is often related to a vasovagal response from straining, and generalized hypersensitivity reactions.

Critical, clinically significant adverse reactions, though rare, include severe allergic events such as anaphylactic reactions and angioedema, as well as reports of ischaemic colitis. The official documentation highlights that severe dehydration and resultant electrolyte imbalance are key safety concerns, particularly associated with prolonged or chronic use. These effects may be more pronounced in certain populations, such as older adults.

Regulatory safety statements indicate that the frequency and severity of abdominal pain and diarrhea are often dose-related. The medicine is intended for short-term use, and prolonged administration is cautioned against in regulatory labels due to potential complications. Furthermore, the medicine is contraindicated in acute abdominal conditions, including severe dehydration, gastrointestinal obstruction, and acute inflammatory bowel diseases, to ensure patient safety.

Overdose and Emergency Response

Laxocodyl Overdose and When to Seek Help

Official regulatory information describes overdose of Laxocodyl (Bisacodyl) primarily through the resulting physiological consequences of excessive intake, rather than a specific toxicity level.

Documented Overdose Presentations and Risks

Feature Official Regulatory Statement (Bisacodyl)
Acute Overdose Manifestations Symptoms include watery stools (diarrhoea), abdominal cramps, and abdominal pain.
Physiological Systems Affected The main risk is a clinically significant loss of fluid and electrolytes (such as potassium), leading to dehydration and hypokalaemia.
Chronic Overdose Risks Prolonged, excessive use is associated with chronic diarrhoea, metabolic alkalosis, renal tubular damage, and muscle weakness secondary to low potassium levels.
High-Risk Populations Dehydration may be particularly harmful for the elderly, young patients (children), and individuals with underlying renal insufficiency.

Mandatory Emergency Actions

Overdose management is symptomatic and supportive, as no specific antidote is known according to regulatory documentation. The procedures detailed include the replacement of fluids and the correction of electrolyte imbalance.

Emergency Action Label-Derived Phrasing (FDA/MedlinePlus)
Required Immediate Action Seek medical help right away if overdose is suspected or has occurred.
Call Emergency Services Call emergency services immediately if the affected person has collapsed, has trouble breathing, or cannot be awakened.
Required Monitoring Monitoring of vital signs, ECG (heart tracing), and blood and urine tests may be required.

This profile guides that all suspected acute or chronic overdose situations involving severe symptoms require professional assessment to address potential fluid and electrolyte complications, particularly in high-risk patients.

Therapeutic Uses of Laxocodyl

What Laxocodyl Treats: Main Uses and Benefits

Laxocodyl is commonly used for symptomatic relief across several key areas of gastrointestinal management. It is applied in addressing symptoms related to physical discomfort from delayed or difficult passage of stool (dyschezia). The medication is relevant for conditions characterized by periods of heightened symptoms, such as occasional, transient constipation and certain forms of chronic or secondary constipation (e.g., opioid-induced constipation).

Laxocodyl is also utilized as a bowel evacuant in clinical contexts, specifically for procedures that require a clear lower gastrointestinal tract, including pre-operative preparation before surgery or cleansing before diagnostic imaging like colonoscopy. The goal of this supportive use is to help ease the overall symptom burden and assist with maintaining functional stability.

“This application is used for managing a necessary evacuation and supporting clearance, which may assist in supporting procedural requirements.”

The medication plays a role in managing symptoms that create noticeable physiological strain, offering supportive relief when symptoms interfere with routine activities.

Quick Fact Relief for Symptomatic Constipation
Primary Focus Infrequent and difficult stool passage (dyschezia)
Clinical Scenarios Acute episodes, chronic secondary constipation, clinical preparation
Key Benefit Contributes to improved comfort and functional stability

Regulatory References

  1. NIH StatPearls overview on Bisacodyl

Eligibility and Restrictions for Use

Who Can and Cannot Use Laxocodyl (Bisacodyl)

The eligibility for using Laxocodyl is strictly defined by regulatory documents, focusing on patient age, reproductive status, and the absence of specific gastrointestinal conditions.

Contraindications (Must Not Use)

Laxocodyl is contraindicated in patients with conditions that pose a severe risk, including intestinal obstruction, bowel perforation, toxic megacolon, or any acute surgical abdomen (such as suspected appendicitis). Use is also prohibited in cases of severe dehydration or severe abdominal pain accompanied by nausea and vomiting where the cause is undiagnosed.

Age-Related Eligibility

Use is established for adults and adolescents (12 years and over). The oral tablet form is generally not recommended for children under six years due to the necessity of swallowing the enteric coating whole. Children under 10 years with chronic constipation should only be treated under the guidance of a physician.

Special Populations

Use during pregnancy is generally not recommended and should be limited to medical advice. Conversely, use during breastfeeding is typically documented as acceptable by regulatory authorities, as the active metabolite is undetectable in breast milk. Patients with certain rare hereditary metabolic disorders, such as lactose or fructose intolerance, are also contraindicated due to the product's excipients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Laxocodyl's official regulatory interaction profile is defined by two primary categories: physicochemical interference and pharmacodynamic effects on systemic electrolytes.

Physicochemical (Coating Integrity) Interactions

Certain medicines and products are documented to cause a physicochemical interaction by leading to the premature dissolution of the tablet's protective enteric coating. This effect is officially noted with substances that reduce upper gastrointestinal acidity, such as Antacids and Proton Pump Inhibitors (PPIs). Additionally, the ingestion of Milk and Dairy Products is strictly prohibited concurrently with the oral tablet. To prevent loss of efficacy and potential gastric irritation, regulatory labels mandate a mandatory administration separation: the Laxocodyl tablet must not be taken within one hour of consuming any of these products.

Pharmacodynamic (Electrolyte) Interactions

Official labeling describes pharmacodynamic interactions related to fluid and electrolyte balance. When Laxocodyl is used in excessive doses, co-administration with Diuretics or Adreno-corticosteroids increases the documented risk of hypokalaemia (low potassium levels). This specific electrolyte disturbance is noted in the official profile as potentially increasing a patient’s sensitivity to the effects of Cardiac Glycosides. Regulatory sources also note that this potential electrolyte risk is more clinically significant in populations experiencing dehydration or fluid loss.

Mechanism of Action

The action of Laxocodyl (Bisacodyl) is achieved through a dual pharmacodynamic mechanism exerted locally by its active form, BHPM (bis-(p-hydroxyphenyl)-pyridyl-2-methane), which is created in the colon from the parent prodrug.


Direct Stimulation of Colonic Nerve Endings

This mechanism engages the enteric neurons of the large intestine, primarily in the submucosal and myenteric plexuses. The BHPM metabolite acts as a localized stimulant to these nerve endings, which enhances the electrical activity of the gut wall. This neural activation triggers the frequent and propulsive muscle contractions known as High Amplitude Propagated Contractions (HAPCs). The resulting physiological effect is an increase in colonic motility that reduces the time required for contents to pass through the colon.


Modulation of Epithelial Fluid Transport

The second domain of action targets the colonic enterocytes. BHPM stimulates the adenylate cyclase enzyme, which initiates a signaling cascade involving cyclic AMP (cAMP). This cascade leads to the active secretion of chloride (Cl⁻) and bicarbonate ions into the lumen, while simultaneously inhibiting the reabsorption of water and sodium ions. The resulting osmotic shift draws water into the colon. This mechanism results in hydration and increased volume of the colonic contents, complementing the propulsive force generated by the nerve stimulation.

Dosage and Administration Information

Laxocodyl is administered via the oral and rectal routes, with the selection depending on the desired time of effect. The enteric-coated tablet is taken orally for a delayed action, typically resulting in a bowel movement 6 to 12 hours later, which often means administration is scheduled at night before bedtime. The suppository or enema is used rectally for a rapid effect, usually acting within 10 to 60 minutes.

The standard adult dosing regimen for occasional constipation begins at 5 mg and may be increased up to 15 mg taken as a single daily dose. For procedures requiring complete bowel evacuation, higher oral doses (up to 20 mg) or a 10 mg suppository may be utilized.

To ensure the medicine works correctly, the oral tablet must be swallowed whole and not chewed or crushed. Furthermore, the tablet should not be taken within one hour of consuming milk or acid-reducing agents like antacids or Proton Pump Inhibitors (PPIs).

Laxocodyl is typically intended for short-term use only, and treatment should generally not exceed 5 to 7 days of continuous administration. Dosage for pediatric patients is often defined as follows: children aged 6 to 12 years are typically given a single 5 mg oral tablet daily.

Recent Clinical Evidence

Laxocodyl: Recent Clinical Evidence

Mechanism and Primary Indication

Laxocodyl is a diphenylmethane derivative that is primarily studied for the short-term relief of occasional constipation. Research indicates its activity involves increasing fluid secretion into the colon and stimulating intestinal movement. The drug's classification as a stimulant laxative reflects its primary method of action on the colonic mucosa.


Efficacy and Clinical Findings

Clinical trials have investigated Laxocodyl's effect on bowel function parameters, focusing mainly on the time until the first bowel movement following administration.

  • Onset of Action: Studies frequently report that oral administration is associated with a latency of 6 to 12 hours before the onset of effect. Rectal administration, primarily explored in specific procedural settings, is associated with a quicker onset, typically within 15 to 60 minutes.
  • Acute Constipation: Placebo-controlled trials have consistently shown that Laxocodyl is generally associated with a higher frequency of successful bowel movements compared to placebo in subjects with acute constipation.

Safety and Tolerability Profile

The safety profile of Laxocodyl has been evaluated across multiple studies. It is generally described as well-tolerated when used for short-term periods as directed.

Common Adverse Reactions (Observed in Studies)
Abdominal discomfort or cramps
Nausea
Diarrhea

Long-term or excessive use of stimulant laxatives, including Laxocodyl, has been explored in observational research for its potential to be associated with dependence or electrolyte imbalances. Due to these considerations, the medication is usually studied and recommended only for short-term use.

Key Studies & References

  1. NICE Guideline: Constipation (CG189) - Management in primary and secondary care

Frequently Asked Questions (FAQ)

Common questions about Laxocodyl (FAQ)


Q: Can people with high blood pressure safely use Laxocodyl?

Official documents indicate that Laxocodyl may interact with certain medicines prescribed for high blood pressure, specifically diuretics. This interaction has been shown to increase the documented risk of hypokalaemia, which is low potassium levels. The medicine is not typically prohibited for high blood pressure alone, but patients are generally informed of the risk of interaction.

Q: Is it true that taking Laxocodyl regularly can lead to dependency?

According to regulatory warnings, chronic or long-term use is associated with the potential for the body to become physically reliant on the medication (dependence). This overuse can also lead to other serious issues like electrolyte imbalances. Official guidance indicates that the medicine is typically intended only for short-term use.

Q: What does the research evidence indicate about the long-term use of Laxocodyl?

Research supporting official safety warnings indicates that prolonged or chronic administration is associated with several risks. These include the potential for severe dehydration, serious electrolyte disturbances, and long-term functional changes in the colon. This evidence is cited in support of the regulatory guidance for short-term use.

Q: Are there any specific foods or drinks that should be avoided when using Laxocodyl?

Regulatory administration instructions strictly mandate that the oral tablet should not be taken within one hour of consuming milk, dairy products, antacids, or proton pump inhibitors (PPIs). This separation is required because these substances may cause the protective tablet coating to dissolve prematurely. No other common foods or non-alcoholic drinks are explicitly prohibited in official materials.

Q: Is it safe to drive or operate heavy machinery after using Laxocodyl?

Official guidance indicates caution is noted regarding driving or operating heavy machinery if a patient experiences certain side effects. Specifically, if dizziness or fainting (syncope) occurs, patients are noted to avoid these activities. Fainting is sometimes noted as a vasovagal response that can occur when straining during a bowel movement.

Q: Why do some official documents include a warning about discontinuing use under certain conditions?

The warning to stop use reflects the fact that the medicine is strictly contraindicated in specific conditions to prevent serious health risks. Laxocodyl is contraindicated in acute abdominal conditions, such as intestinal obstruction or severe, undiagnosed abdominal pain, to prevent complications like bowel perforation.

Q: What is the definition of a 'contraindication' for Laxocodyl, as listed in official documents?

In regulatory terminology, a contraindication defines a condition or circumstance where the medicine must not be used. This definition is based on the determination by regulatory bodies that, under these conditions, the potential risk of harm is considered to outweigh any potential therapeutic benefit.

Q: What happens to the body if the instructions for using Laxocodyl are not followed precisely?

If administration instructions are not followed, such as taking the tablet with milk, the medicine may be released prematurely in the stomach, leading to gastric irritation and reduced efficacy. Furthermore, reports indicate that using the medicine excessively or chronically may lead to more serious risks, including severe diarrhea, dehydration, and a dangerous imbalance of electrolytes.

Q: How does Laxocodyl differ from other common over-the-counter options in its class?

Regulatory information classifies Laxocodyl as a stimulant laxative, meaning it actively prompts the bowel's natural muscle movement and increases fluid secretion into the colon. This specific dual mechanism serves as a primary way to distinguish it from other types of medicines, such as bulk-forming laxatives or osmotic agents.

Q: Is Laxocodyl considered a prescription-only medicine or is it available over-the-counter?

Laxocodyl is widely available for purchase over-the-counter (OTC) in specific pack sizes intended for short-term, occasional use. It is also available by prescription for specific medical indications or procedures, such as preparing the bowel for a medical test.

Q: Can consuming alcohol affect how Laxocodyl works in the body?

Public health guidance states that consuming alcohol does not have a documented clinical interaction that directly affects the drug's mechanism of action. However, because Laxocodyl works by increasing fluid secretion, it is generally recommended that adequate hydration be maintained, which may be impacted by alcohol consumption.

Q: Does Laxocodyl interact with common vitamin and mineral supplements?

Official cautions state that there is insufficient clinical evidence regarding potential interactions between Laxocodyl and complementary medicines, herbal remedies, or general vitamin supplements. For safety, regulatory guidance often suggests that patients inform their healthcare provider of any supplements being taken.

Q: Has Laxocodyl been studied for use in patients with underlying chronic gastrointestinal conditions?

While some clinical research has explored the use of Laxocodyl in specific chronic conditions like slow-transit constipation, official regulatory documentation generally establishes its approved purpose as the short-term relief of occasional constipation.

Q: What should a person generally do if they forget to use a dose of Laxocodyl?

Official patient guidance notes that since the medicine is generally used on an as-needed basis for occasional constipation, a patient should continue with their next scheduled dose. Guidance indicates that a double dose should not be taken to compensate for a missed dose.

Q: How do regulatory bodies classify the potential for abuse or misuse of Laxocodyl?

Regulatory bodies have acknowledged the potential for misuse and overuse, particularly within certain patient populations. In response to this risk, measures such as pack size restrictions have been implemented for over-the-counter sales of the product.

Q: Can using Laxocodyl cause a noticeable change in a person's weight?

Laxocodyl is not officially indicated or approved for weight loss. However, regulatory warnings note that chronic overuse or high dosing may result in persistent diarrhea and loss of nutritional factors from the body, which may lead to unintended weight loss.

Q: Does the effectiveness of Laxocodyl decrease or plateau with repeated use?

Regulatory documents caution that chronic or habitual use may lead to a loss of normal colonic function over time. This decrease in effectiveness may be accompanied by structural changes to the colon, a condition sometimes referred to as cathartic colon.

Q: Can Laxocodyl be used by people who have existing kidney function concerns?

Laxocodyl is generally considered safe for use in patients with existing kidney function concerns or renal impairment. This is because the medicine acts locally within the intestine and exhibits minimal systemic absorption into the bloodstream.

Q: Are there any known interactions between Laxocodyl and common non-prescription cold or flu medications?

Official interaction checks with common multi-symptom cold and flu products have generally found no direct or serious interactions with Laxocodyl. However, the general caution regarding maintaining proper fluid balance to avoid dehydration remains applicable.

Q: What is the difference between a common side effect and a serious adverse event for Laxocodyl?

Official patient documentation classifies potential problems into specific categories to guide patients on the appropriate course of action. This differentiates Common side effects, which are generally mild and expected (like abdominal cramping), from Rare or Critical adverse events (like anaphylaxis), where immediate medical review is noted.

Q: Is it necessary to drink extra water while using Laxocodyl?

Official guidance indicates that maintaining adequate hydration and fluid intake is noted while using the medicine. This is particularly important because the medicine's mechanism of action involves increasing the secretion of fluid into the colon, which can increase the risk of dehydration if fluid intake is insufficient.

Q: Can people with diabetes safely use Laxocodyl?

Regulatory guidance and clinical practice guidelines indicate that Laxocodyl is considered appropriate for use in managing constipation associated with diabetes. However, it is generally noted that patients with diabetes may need to monitor their blood sugar levels carefully, especially if using the medicine as part of a bowel preparation regimen for a procedure.

Q: What does official guidance say about accidentally using more Laxocodyl than intended?

Official warnings indicate that accidentally using more Laxocodyl than intended can lead to serious adverse effects, including severe diarrhea and a serious electrolyte imbalance. Immediate medical review is noted in the event of an overdose, and patients are typically advised to contact Poison Control.

Q: Is there a specific patient information leaflet (PIL) for different forms of Laxocodyl?

Yes, official Patient Information Leaflets (PILs) or Package Inserts are created and approved by regulatory bodies for all available forms and strengths of Laxocodyl. These documents provide detailed safety warnings, administration guidelines, and information for the patient.

Q: Why is Laxocodyl sometimes preferred over bulk-forming medicines for certain uses?

Official clinical guidelines indicate that Laxocodyl may be preferred over other classes of medicines, such as certain bulk-forming or magnesium-containing osmotic laxatives, for specific patient populations. For example, it may be favored for use in patients with end-stage renal disease (ESRD) due to specific safety considerations.

How should Laxocodyl be stored and disposed of?

How to Store and Dispose of Laxocodyl?

The proper storage and disposal of Laxocodyl (Bisacodyl) are governed by specific regulatory requirements to ensure product stability and safety.

Storage Requirements

  • Temperature: Store most formulations at controlled room temperature, typically 25 C (77 F), with permitted excursions up to 30 C (86 F). A specific rectal suspension form requires refrigerated storage (2 C to 8 C).
  • Environment: The medicine must be kept protected from moisture and excessive humidity; some forms, like suppositories, must also be protected from light.
  • Container Integrity: Keep the medicine in its original container, tightly closed. Do not use the product if the outer seal or individual blister unit is torn or broken.
  • Child Safety: There is a universal, mandatory requirement to keep this medication out of reach of children.

Disposal Instructions

Any unused or expired Laxocodyl must be disposed of in accordance with local requirements for drug take-back or pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Laxocodyl found in:

A-Z Index: